These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 8643201)
1. Worsening of renal function in a renal transplant patient treated with granulocyte colony-stimulating factor. Minguez C; Mazuecos A; Ceballos M; Tejuca F; Rivero M Nephrol Dial Transplant; 1995 Nov; 10(11):2166-7. PubMed ID: 8643201 [No Abstract] [Full Text] [Related]
2. Severe neutropenia after renal transplantation and its reversal with granulocyte colony-stimulating factor. Birkeland SA; Elbirk A; Rohr N; Jørgensen KA Transplant Proc; 1994 Dec; 26(6):3098-9. PubMed ID: 7527945 [No Abstract] [Full Text] [Related]
3. [G-CSF versus GM-CSF in the treatment of neutropenia in a patient with Felty's syndrome on hemodialysis]. del Pozo C; Ortiz de Salazar MI; Torregrosa I; Sánchez L; Albero MD; Bauza J Nefrologia; 2000; 20(5):455-8. PubMed ID: 11100668 [TBL] [Abstract][Full Text] [Related]
4. Role of granulocyte colony stimulating factor (G-CSF) in reversing neutropenia in renal allograft recipients. Peddi VR; Hariharan S; Schroeder TJ; First MR Clin Transplant; 1996 Feb; 10(1 Pt 1):20-3. PubMed ID: 8652892 [TBL] [Abstract][Full Text] [Related]
5. The use of granulocyte colony-stimulating factor in a neutropenic renal transplant recipient. Derici U; Ayerdem F; Arinsoy T; Reis KA; Dalgic A; Sindel S Haematologia (Budap); 2002; 32(4):557-60. PubMed ID: 12803133 [TBL] [Abstract][Full Text] [Related]
6. [The dilemma of stimulating factors in the recovery from chemotherapeutic neutropenia]. Borbollo Escoboza JR; González Avante M; Alvarado Ibarra M Rev Invest Clin; 1996; 48(4):328. PubMed ID: 8966397 [No Abstract] [Full Text] [Related]
7. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy. Wong SF; Chan HO Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284 [TBL] [Abstract][Full Text] [Related]
8. MPGN type I induced by granulocyte colony stimulating factor. Magen D; Mandel H; Berant M; Ben-Izhak O; Zelikovic I Pediatr Nephrol; 2002 May; 17(5):370-2. PubMed ID: 12042897 [TBL] [Abstract][Full Text] [Related]
9. [Resolution with vascular endoprosthesis after first angioplasty failure in the treatment of post-transplant stenosis of the renal artery]. Rodríguez-Miñón Cifuentes JL; Abad Cervero J; Plaza Pérez J; Castillón Vela I; Sánchez Gómez FJ; Vela Navarrete R Actas Urol Esp; 1997 Sep; 21(8):793-6. PubMed ID: 9412233 [TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of granulocyte-colony stimulating factor in scleromyxoedema associated with severe idiopathic neutropenia. Cohen AM; Hodak E; David M; Mittelman M; Gal R; Stern R Br J Dermatol; 1996 Oct; 135(4):626-9. PubMed ID: 8915161 [TBL] [Abstract][Full Text] [Related]
11. Recombinant granulocyte colony-stimulating factor in the management of toxic epidermal necrolysis. Goulden V; Goodfield MJ Br J Dermatol; 1996 Aug; 135(2):305-6. PubMed ID: 8881680 [TBL] [Abstract][Full Text] [Related]
12. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF]. Borota R; Borota J; Belić A; Gebauer E; Stefanović N Med Pregl; 1997; 50(3-4):87-93. PubMed ID: 9229690 [TBL] [Abstract][Full Text] [Related]
13. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies. Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099 [TBL] [Abstract][Full Text] [Related]
14. The effect of granulocyte colony stimulating factor on neutrophil functions in children with neutropenia after chemotherapy in the course of neoplasma. Czygier M; Dakowicz Ł; Szmitkowski M Adv Med Sci; 2007; 52():143-6. PubMed ID: 18217407 [TBL] [Abstract][Full Text] [Related]
15. [Growth factors in oncology: effectiveness and prospects]. Ottmann OG; Hoelzer D Praxis (Bern 1994); 1998 Sep; 87(36):1153-9. PubMed ID: 9782744 [TBL] [Abstract][Full Text] [Related]
16. Ernie: a case study of a renal transplant patient. Moffatt AK Nephrol Nurse; 1981; 3(6):26-32. PubMed ID: 7029326 [No Abstract] [Full Text] [Related]
17. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients. Page AV; Liles WC Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545 [TBL] [Abstract][Full Text] [Related]
18. [Granulocyte colony-stimulating factor in the treatment of neutropenia associated with HIV infection]. Moreno García M; Fernández González F; Fernández Rodríguez E; Portús de Marco MV Med Clin (Barc); 1996 Jul; 107(6):237-8. PubMed ID: 8755453 [No Abstract] [Full Text] [Related]
19. The effects of prolonged angiotensin-converting enzyme inhibition on excretory kidney function and proteinuria in renal allograft recipients with chronic progressive transplant failure. Barnas U; Schmidt A; Haas M; Oberbauer R; Mayer G Nephrol Dial Transplant; 1996 Sep; 11(9):1822-4. PubMed ID: 8918629 [No Abstract] [Full Text] [Related]
20. Effect of hematopoietic cytokines on renal function in cisplatin-induced ARF in mice. Nishida M; Fujimoto S; Toiyama K; Sato H; Hamaoka K Biochem Biophys Res Commun; 2004 Nov; 324(1):341-7. PubMed ID: 15465024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]